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1.1 Professional abstract 
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are the 
subgroup of the carcinoembryonic antigen family (CEA) which belongs to the 
immunoglobulin (Ig) superfamily. Herpes simplex virus type 1 (HSV-1) belongs to 
the subfamily of Alpha-herpesvirinae, which causes the overt infection by 
contacting with the secretions of an infected individual. Previous studies indicated 
the interaction between CEACAM proteins and HSV-1 via the siRNA depletion 
screen and the yeast two-hybrid (Y2H) system. The application of siRNA 
knockdown screen showed that CEACAM7 as a cellular protein required for viral 
replication, Y2H found the interaction between CEACAM family and glycoproteins. 
These results led to our hypothesis that CEACAM protein family may function as 
the viral entry receptor.  
In this project, we carried out several independent experiments in order to confirm 
the role of CEACAMs in HSV-1 viral entry. Transient overexpression of CEACAMs 
on HSV-1 viral-permissive cell lines (HeLa and 293T cells) led to a significant 
increase in viral replication. The interaction between CEACAM proteins and viral 
glycoproteins (gB, gD, gH) was confirmed by both Luminescence-based 
mammalian interactome mapping (LUMIER) assay and Co-immunoprecipitation 
assay. Finally, overexpression of CEACAM on viral non-permissive CHO cells 
identified the increase of HSV-1 early infection events when co-expressed with 
human receptors (HVEM or Nectin). 
Therefore, in this study, all the results suggested that CEACAM protein family may 











1.2 Layman’s abstract 
Herpes simplex virus type 1 (HSV-1) is distributed worldwide, and it is estimated 
that the risk of getting infection can be as high as 80%-85% for adults. This 
prevalently contagious virus causes a variety of human diseases when people get 
acute infection, including oral cold sores, fever, headache, herpes keratitis and 
genital sores, especially children under 5 years old are susceptible to HSV-1. In 
addition, HSV-1 infected people may also undergo the latent infection which results 
in the potential risk that HSV-1 virus may sneak on the body nervous system. 
Therefore, it is important to understand and investigate the pathway of HSV-1 viral 
entry into human host cell. 
Previous research in our lab has analysed that carcinoembryonic antigen-related 
cell adhesion molecules (CEACAMs) are likely to be a new class of cellular receptor 
for HSV-1 viral entry. We found that CEACAMs were implicated in HSV-1 based on 
the previous work. It showed that the depletion of cell surface molecules (including 
CEACAM7) with deconvoluted small interfering RNA smart pools inhibited HSV-1 
replication. Furthermore, the interaction between several CEACAM proteins and 
HSV-1 viral glycoproteins was confirm as well through a protein-protein interaction 
screen called yeast two-hybrid.  
In this study, several techniques were introduced to further prove our hypothesis 
and to analyse the role of CEACAM protein family in HSV-1 membrane fusion, 
infection, gene expression and viral replication. The results from this project 
indicated that there was an obvious increase of HSV-1 viral replication when 
CEACAMs were transiently overexpressed into viral-permissive cells. Meanwhile, 
we confirmed CEACAM proteins could physically interact with HSV-1 viral 
glycoproteins. Finally, overexpressed CEACAM proteins in viral non-permissive 
cells enabled to promote the early HSV-1 infection event when combined with other 
human receptors. 
Therefore, our research aims to understand that CEACAM receptor may potentially 









2.1 HSV disease 
      2.1.1 Herpes simplex viruses 
There are two subtypes of herpesvirus which are herpes simplex virus type 1 (HSV-
1) and herpes simplex virus type 2 (HSV-2), they both belong to the large human 
herpesviridae family. These DNA viruses are ubiquitous and contagious, both HSV-
1 and HSV-2 cause infectious diseases in humans. All herpesviruses have 
morphological similarity, and on the basis of their biological and virologic properties 
and DNA sequence homology and genome arrangement, they are classified into 
three subfamilies, which are Alpha-herpesvirinae (including HSV-1 and HSV-2), 
Beta-herpesvirinae, and Gamma-herpesvirinae. The defining characteristic of 
herpesviruses is their ability to establish the latent infection, combing with specific 
genome of virus into host chromosomes (Kenneth et al., 2004). 
      2.1.2 Epidemiology and pathogenesis 
Herpesviruses are highly disseminated in nature, and widely distribute in both 
developing and developed countries. The most common route of transmission for 
herpes simplex virus (HSV) is contacting with an infected person who is shedding 
the virus, or by in contact with contaminated secretions directly. According to the 
previous clinical report, the contact infection from one anatomical site to another is 
the primary route of transmission, which indicates that the risk of getting infection 
can be as high as 80%-85% for adults through this route. Apart from the anatomic 
involvement, the infection also depends on the individual age and immune status 
of the host as well as the antigenic virus type. HSV-1 causes cold sores on mouth 
and lips, gingivostomatitis or ulcerative lesions, the primary infection of HSV-1 
usually occurs among very young children, especially the peak of incidence is 
around 5 years old. In addition, HSV-1 as neuroinvasive virus may become latent 
and hide in the neurons of human bodies. The major infection of HSV-2 is often 
postponed until adolescent age and coincides with the sexual activity, therefore 
genital disease is mainly caused by sexual transmission for both HSV-1 and HSV-
2 (Gupta et al., 2007; Schiffer et al., 2014; Sperling et al., 2008). 
The first step of clinical pathogenesis is primary infection. The manifestation is 
acute herpetic lesion or whitlow. Saliva, skin blister and infected mucous membrane 
area are the main modes of infection, the contact triggers the formation of vesicle 
for non-immune person. Vesicular lesions would continue seven days and viral 
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shedding lasts at least three weeks. After the primary infection, herpesvirus may 
conceal in sensory nerve for life long, typically persist in the trigeminal ganglia 
(HSV-1) and in the sacral ganglia (HSV-2). These non-eradicated herpesviruses 
come from the latent state cannot be recognised by the immune system and might 
be reactivated over time, but the mechanism by which recurrence occurs is 
unknown (Gupta et al., 2007; Koelle & Corey, 2007). 
      2.1.3 Treatment and prevention 
The long-term outlook of HSV is that people who get infection will have the virus for 
the rest of their lives, even though it does not manifest symptoms. After the virus 
becomes dormant, some people may also experience regular outbreaks with 
certain stimuli, including stress, fever, menstrual periods, and sun exposure. 
Treatment always focuses on getting rid of cold sores and limiting outbreaks, 
medications (such as acyclovir, famciclovir, valacyclovir) help to reduce the 
intensity and frequency of outbreaks and lower the risk of recurrence.  
The obvious way of decreasing the risk of infection is to avoid direct physical 
contact with lesion. It is also believed that the body may start to create antibodies 
through immune system over time. If a generally healthy individual has been 
infected with the virus, there are usually no complications. People can take 
precautionary measures to avoid becoming infected, or to prevent spreading HSV 
to another person as well. Meanwhile, share the daily items can also pass the virus 
around, such as cups, towels, clothing, makeup, or lip balm. It is also recommended 
that infected individuals should not participate in oral sex, kissing, or any other type 
of sexual activity, during an outbreak. Additionally, washing hands thoroughly and 
frequently to reduce the risk. Women who are pregnant and infected may have to 
take medicine to prevent the virus from infecting their unborn babies (Corey & Wald, 
2009; Kimberlin, 2007). 
 
2.2 HSV-1 virus 
      2.2.1 HSV-1 structure 
           2.2.1.1 Virus structure 
All herpesviruses share similar structural properties. The virion size varies from 180 
to 300nm due to the thickness of tegument (see below). The structure of HSV-1 
contains a large double-strained linear DNA genome inside the core, which the 
diameter is around 75nm (Whitley et al., 1996). The nucleus is established with an 
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icosahedral capsid, this nucleocapsid is 100-110nm in diameter which has 162 
capsomeres. Tegument is the protein-filled amorphous structure between capsid 
and envelop, this region includes viral enzymes, some of which take control of the 
cellular chemical process, virion production and defence against immediate 
response of host cells. Outside, the tegument is encased by a trilaminar lipoprotein 
membrane called envelope, derived from the cell membrane. Within the envelope 
is a dozen of virus coded glycoprotein spikes, these glycoproteins offer adherent 









Figure 1: HSV-1 virus structure. The herpesvirus virion consists of five main structural 
elements. The core contains linear DNA, which is covered with nucleocapsid. Tegument is 
protein structure between capsid and envelop out layer. Envelop is cellular membrane with 
glycoprotein spikes on the surface (Taken from http://ukulelejohn.com/tag/structure). 
 
           2.2.1.2 Genome structure and organization 
The HSV-1 viral genome is a large double-strained linear DNA, the length ranges 
from 120,000 to 230,000 base pairs with a base composition of 70% G+C, and 
contains 60 to 120 genes (Pertel & Spear, 1999). The genome can be classified 
into two unique segments, unique long (UL) region and unique short (US) region, 
both of which encode distinct open reading frames (ORFs). Among the 74 known 
ORFs, at least 56 viral genes belong to UL, whereas US contains 12 ORFs 
(McGeoch DJ, 2006). The UL is bounded by a terminal repeat long region (TRL) 
and an inverted internal repeat long region (IRL). The US is similarly bounded by a 
terminal repeat short region (TRS) and an inverted internal repeat short region 
(IRS). The inverted repeats allow rearrangement of unique regions, these inverted 
repeats contain sequences that required for the viral genome packaging or 
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cleavage (Salameh et al., 2012). The long repeat (RL) is about 9,000 base pair, 
encode immediate early protein and promoter as well as genes for the latency 
associated transcript (LAT). The short repeat (RS) is about 6,600 base pairs, also 
encode immediate early protein and work as transcriptional activator to provoke 
viral gene expression and stimulate viral replication (Edward, 2003). There are 
three different stages of virus genome: linear, circular (after infection), and 
concatemeric, but the mechanism of genome circularization has not been 
established (McGeoch et al., 2006; Mettenleiter et al., 2006). 
      2.2.2 HSV-1 viral entry 
           2.2.2.1 Viral entry routes  
The HSV-1 entry mechanism is a multistep process, there are two principle routes 
of viral entry. The first pathway contains both attachment and penetration, HSV-1 
virus attaches to cell membrane results in the interaction between viral glycoprotein 
and host cell membrane, which allows the entry of viral capsid into host cells. In 
this pathway, the first step is that glycoproteins gB and gC attach to heparan 
sulphate proteoglycan (HSPG) on host cell in order to concentrate virus particles 
on cell surface, which transport is known as viral surfing. The next process is the 
interaction between cellular receptor and the specific gD receptor of HSV-1, this 
interaction invades viral fusion to the cell membrane and brings both viral envelop 
and cell plasma membrane into close juxtaposition (Campadelli-Fiume et al., 2000). 
During the fusion, gD undergoes a conformational change when binging to cellular 
receptor, which assembly transmit a signal to activate the fusion machinery, gH and 
gL interact with cell receptors also stimulate the fusion (Karasneh & Shukla, 2011). 
The naked viral capsid is released into cytoplasm after the fusion and the incoming 
viral nucleocapsid is transported into nucleus, and finally targeted to the nuclear 
pore where the viral genome is uncoated for viral transcription and replication in the 
nucleoplasm (Spear and Longnecker, 2003). The second mode is that HSV-1 virion 
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can enter into cells by fusing with cell surface which is called endocytic pathway 
(Fig.2). 
 
Figure 2: Pathway of HSV-1 viral entry into host cell. I: HSV-1 can attach and fuse with cell 
surface and enter into the cell cytoplasm. II: Endocytosis. a) Virus delivers to the membrane 
protrusion on cell surface. b) Through the phagocytic function, the virus would enter into cells 
and towards to the cell nucleus. c) The viral envelope fuses with the membrane. d) The naked 
viral nucleus capsid is released. e) The subsequent entry into nucleus (Salameh S, 2012). 
 
           2.2.2.2 Glycoproteins and receptors in the viral entry process 
There are four necessary glycoproteins encoded by the HSV-1 genome for the viral 
fusion which are gB, gD, gH, gL. gB (encoded by UL27) is the principle mediator of 
initial attachment with HSPG as well as enhance the overall binding of virus 
particles to cell surface in the initial interaction. gD (encoded by US6) is the major 
receptor which is able to  bind to the specific cellular receptors, including 
herpesvirus entry mediator (HVEM), nectin-1/-2 and 3-O sulfated heparan sulfate 
(3-O HS) (Salameh et al., 2012). gH (encoded by UL22) is activated followed by 
gD structural change and in turn regulates activation of gB (Atanasiu et al., 2010). 
gL (encoded by UL1) form a dimer with gH, modulating gH and regulating its activity 
by ensuring it has been processed correctly and inserted in the membrane (Gianni 
et al., 2010). 
HVEM which belongs to tumor necrosis factor (TNF) receptor family is the first gD 
receptor. Nectin-1/-2 are the members of immunoglobulin superfamily (Ig) and can 
also mediate viral entry by binding with gD. 3-O HS is another receptor for gD, the 
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function of 3-O HS is either triggering viral entry or inducing cell fusion (Karasneh 
& Shukla, 2011). The binding between gD and one of these three cognate receptors 
may lead to the conformational changes of gD, and interact with gB, gH, gL, which 
together form a fusion active complex.     
       2.2.3 HSV-1 replication cycle 
There are two routes of virus replication, which are productive replication cycle and 
latent infection. For the former infection, three distinct processes of gene 
transcription and protein synthesis are initiated when virus entry into the host cell 
nucleus, which are the immediate-early, early, and late proteins. The cellular DNA 
repair enzymes may circularise the viral DNA when migrates to nucleus pore. For 
the latent infection, viral DNA remains linear and inhibits cellular DNA repair or 
amplify, also there is no viral gene expression for the replication (Boehmer & 
Nimonkar, 2003). 
           2.2.3.1 Immediate-early gene expression 
Immediate-early (IE) gene expression is the first stage of HSV-1 viral transcription 
after the viral DNA migrates into the cell nucleus, accompanied by some tegument 
proteins or regulators. VP16 (also known as α-TIF) is presenting in the virion protein 
and is essential for the expression of the immediate-early genes (Francisco et al., 
2004). During the immediate-early infection, virion associated VP16 interacts with 
cellular regulators Oct-1 and host cell factor (HCF), and directly bind to a 
“TAATGARAT sequences” element in IE enhancers, which then forms a ternary 
complex. VP16 also stimulates the RNA polymerase II (RNA Pol II) by interacting 
with mediator components such as TATA box in order to further activate the 
transcription of immediate-early entry infection (Triezenberg et al., 1988; Spector 
et al., 1991; Herrera et al., 2004). In addition, another regulator is called virion host 
shutoff (VHS) protein, aims to degrade host mRNA and regulate viral gene 
expression (Smibert et al., 1994; Matis & Kudelova, 2001).  
VP16 induces the expression of the immediate-early (IE) transcripts which are 
ICP4, ICP0, ICP27, ICP22, ICP47. They modulate with VP16 which strongly 
activate the IE gene expression, and IE genes drive the expression of early 
transcription. The immediate-early transcription occurs at promoters upon the viral 
genomes enter the cell nucleus. ICP4 and ICP27 are essentially required for viral 
replication and transactivation, ICP0 is the crucial factor for paving the way of viral 
replication and for transacting promoters, the function of ICP22 and ICP47 are 
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maintaining capability of virus and mediating infection response (Edward, 2003; 
Pritchard et al., 2013; Wagner & DeLuca, 2013). 
           2.2.3.2 Early and late gene expression 
During these two stages of lytic gene expression, protein products can be detected, 
and proteins produced from early stage such as DNA polymerase (UL30) and DNA 
binding proteins (UL42, UL29), are then used in the regulation of HSV-1 viral 
genetic replication. Proteins from late stage are important components for the late 
kinetics, which applied to package the capsid. DNA replication significantly 
influences on the viral gene expression, which followed by the late gene expression 
(Edward, 2003).  
           2.2.3.3 Envelopment and release 
There are three different pathways for envelopment, the primary envelopment (at 
inner nucleus membrane), the de-envelopment (at outer nuclear membrane), and 
reenvelopment (at trans-Golgi network) (Leuzinger et al., 2005).  
The primary envelopment occurs at the inner nuclear membrane. The neonatal 
nuclear capsids migrate into the perinuclear space, during which process tegument 
and the dense envelope are produced. Then virons transfer to the cell rough 
endoplasmic reticulum (RER) cisternae from the perinuclear space, and the pre-
existing dense envelope helps the transportation of virions from RER to Golgi 
cisternae where several virions are packed into the large vacuoles (Leuzinger et 
al., 2005). For the de-envelopment, cytoplasmic capsids are formed at outer 
nuclear membrane. Finally, single virion is released from the vacuole and travel to 
the cell surface with Golgi-derived vesicles, producing the mature infectious 
particles and get released from cells by fusing with plasma membrane (Granzow et 
al., 2001). 
 
2.3 CEACAM proteins family 
The carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) belong 
to a subgroup of the carcinoembryonic antigen (CEA) family, which are members 
of the immunoglobulin (Ig) superfamily (Zebhasuer et al., 2005). Each CEACAM 
plays a precise physiological role as the modulator, such as cell adhesion, cell 
recognition and regulation, tissue architecture and proliferation, tumor progression 
and suppression, especially different CEACAMs can mediate cell signal 
transfection and integrate signal into functional human organs, as well as intersect 
with other cellular reporters (Tchoupa et al., 2014).  
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The human CEACAM family includes 12 encoded genes (Fig.3). All CEACAM 
members have the immunoglobulin (Ig)-like domains, the functional Ig fold provides 
an interface for efficient protein-protein binding region (Kuespert et al., 2006). Ig-
like domain can be subdivided into Ig variable (IgV) and Ig constant -1/-2 
(IgC1/IgC2) domains based on the variability of amino acids sequences long 
(Kuespert et al., 2006). Each CEACAM consists of the specific N-terminal IgV-like 
domain and IgC2-like domain, the IgC2-like domain is ranging from zero to six 
numbers of glycosylation sites with either A or B subtype. These surface expressed 
domains connect with the cell membrane through either the glycosyl phosphatidyl 
inositol (GPI) anchors or transmembrane (TM) domain (Tchoupa et al., 2014; Varki 
et al., 2009).  
All the physiological functions rely on the homophobic and heterophilic interactions 
among CEACAM IgV-like domains, which makes the intercellular adhesion come 
true (Taheri et al., 2000). Interestingly, some CEACAM members have glycosylated 
extracellular domains, for examples, CEACAM1 has one extracellular amino-
terminal IgV-like domain with 11 isoforms. CAECAM6 also has six extracellular 
IgC2-like domains followed single IgV-like domain. However, differ from the 
epithelial CEACAM1 and CEACAM6, there is no homophobic and heterophilic 
interaction on the extracellular IgV-like domain of CEACAM3, but undergoes 








Figure 3: The members of human CEACAM family. The red tops are N-terminal IgV-like 
domains. The blue spheres are 0-6 numbers of IgC2-like domains with A or B subset. Both green 
arrows and green helices are GPI anchors and TM domains respectively. The black sticks which 
around each spheres are extracellular domains. Some CEACAMs may have different length of 
ending cytoplasmic tails, some CEACAMs have distinctive splice variants. CEACAM16 is 




2.4 Previous work 
The CEACAM protein family has already been confirmed to act as cellular receptors 
of some pathogens for both entry and attachment (Muenzner et al.,2008). For 
example, CEACAM1 is known as the major pathogen receptor for mouse hepatitis 
virus (MHV) entry which is a murine coronavirus and is also postulated as the 
receptor for human coronavirus severe acute respiratory syndrome (SARS) 
(Hemmila et al., 2004). CEACAM1, CEACAM3, CEACAM5, CEACAM6 enable to 
interact with a range of gram-negative bacterials such as Moraxella catarrhalis, 
Neisseria gonorrhoeae, N. Meningitidis, and Haemophilus influenzae (Voges et al., 
2010).  
The fact that CEACAMs act as receptor for these pathogens led to our hypothesis 
that CEACAM protein family may be a novel receptor also for HSV-1. Therefore, 
there were two previous experiments have been done to investigate our hypothesis.  
       2.4.1 siRNA depletion screen 
The small-interfering RNA (siRNA) depletion screen is a powerful technique for 
phenotypic assay which can be introduced to investigate the virus-host interaction. 
Previous application of this siRNA depletion screen in our lab has identified the 
functional role of some cell surface molecules for HSV-1 viral replication. 
Briefly, by screening a druggable genome siRNA library, huge amount of human 
genes was targeted against HSV-1 virus which monitored by the reporter of 
expressed green fluorescent protein (GFP). This siRNA knockdown screen was 
carried out into triplicate, one replicate aimed to test the cytotoxic effect of gene 
depletion through a cell viability assay, whilst other two replicates were infected 
with HSV-1 virus. The siRNA library was transfected into viral-permissive cell line 
(HeLa cells) line reversely and then infected with HSV-1, virus growth was recorded 
by measuring the number of GFP reporter signal (the relative fluorescent units). By 
calculating the slope from the linear growth carve and comparing with mock-
transfected cells control, we identified that some genes (both pro-viral genes and 
anti-viral genes) influenced HSV-1 growth (Griffiths et al., 2013). 
A significant reduction of HSV-1 viral replication was revealed when conducted the 
depletion of several CEACAM members. Specifically, we found the knockdown of 
CEACAM7 inhibited HSV-1 viral replication, which led to a hypothesis that human 
CAECAMs might play a role in HSV-1 viral entry receptor. 
       2.4.2 CEACAM proteins bind to HSV-1 membrane glycoproteins 
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A genome-scale yeast two-hybrid (Y2H) protein interaction screen was carried out 
to investigate the infection of viral proteins partner in parallel with siRNA depletion 
screen. As a result, the interactions were tested between gH∆sp, gD baits and 
several CEACAMs preys. Specifically, CEACAM8 (in prey) interacted with gH∆sp 
(in bait) was confirmed, CEACAM19 paired with gD was detected based on the 
high activity of α-galactosidase.  
Therefore, the functional data from siRNA depletion screen and the interaction data 
from Y2H suggested that CEACAM family may act as a novel class of receptor for 



























3. Hypothesis and aims  
 
The hypothesis is that CEACAM protein family represents a novel class of entry 
receptor for HSV-1 and they could bind to HSV-1 membrane glycoproteins. 
 
In this project, the main aim is to further investigate the role of CEACAMs in HSV-
1 entry and their replications. Specifically, in my project, the aims are: 
1) To confirm the phenotype of CEACAMs on HSV replication using gain-of-
function over expression experiments;  
2) To validate the interactions between CEACAMS and glycoproteins via LUMIER 
assays and Co-Immunoprecipitation; 



















4. Materials and methods 
4.1 Cell lines and virus stock 
      4.1.1 Cell lines  
HeLa cell:  The cell type is a human epithelial cell which derived from a cervical 
carcinoma. 
293T cell: The cell type is a human epithelial cell which derived from human 
embryonic kidney. The parental line of 293T is HEK293, the difference between 
these two cell lines is that 293T cells contain large “T” antigen transformed which 
is important to replicate plasmids and to produce sufficient titer. 
CHO cell: CHO is an abbreviation for Chinese Hamster Ovary. This laboratory 
cultured cell line is a good mammalian cell model and frequently used for 
expression of recombinant proteins. Particularly, CHO cells are non-permissive to 
HSV-1 infection, because they do not express human receptors (HVEM or Nectin), 
and they also have post-entry block to HSV-1 viral replication. 
     4.1.2 Tissue culture technique 
DMEM growth medium was prepared with 5% FCS and 1% Pen-Strep (Appendix 
A), medium and reagents (i.e. PBS, Trypsin) were warmed up in 37°C water bath 
before use. Cell lines were maintained in the flask (all the milliliter below was based 
on T75 flask), washed the flask with 10 ml PBS to remove FCS which inhibits 
activity of trypsin, then 2 ml trypsin was added and incubated 10-15 minutes in 
37°C/ 5% CO2 incubator until all the cells float up, then neutralized the trypsin by 
adding 8 ml medium, pipetted the medium up and down to make sure the single 
cell suspension. Transfer the cells and appropriate volume of medium to a new 
flask, mixed well and put back to the incubator as the next new cell passage. 
Splitting the cells when the cell confluence gets 70-80%. 
Cells were maintained in DMEM/ 5% FCS/ 1% Pen-Step (293T; HeLa; SK-N-SH) 
or DMEM/F-12/ 5% FCS/ 1% Pen-Step (CHO). 
     4.1.3 Virus stock 
Herpes Simplex Virus type1 (HSV-1) strain C12, which contains GFP as the 
fluorescent reporter in stock (Arthur et al, 2001). 
 
4.2 Isolation of DNA and restriction digest 
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     4.2.1 DNA amplification 
For small-scale isolation of DNA from bacteria, an existing glycerol stock of 
transformed bacteria was streaked on a LB-agar plate (Appendix A) with 
appropriate antibiotic (Appendix B), and the plate was incubated with the agar on 
the top at 37°C overnight in a dry incubator. The next day, a single colony was 
picked using a pipette tip and dropped the tip into a 15 ml centrifuge tube which 
containing 5ml LB medium with the selective antibiotic, and incubated in an orbital 
shaker overnight at 200 rpm/37°C. For large-scale isolation of DNA from bacterial, 
200 ml LB medium was transferred (Appendix A) with appropriate antibiotic 
(Appendix B) to a sterile glass conical flask, then inoculated with 500 μl glycerol 
stock of bacteria culture, and incubated in an orbital shaker overnight at 200 
rpm/37°C.  
     4.2.2 DNA purification 
DNA was extracted from small-scale volumes with QIAGEN® Mini-Prep. According 
to manufacture protocol, 300 μl bacterial culture was mixed with 300 μl 50% 
glycerol to make a long-term glycerol stock at -20°C. The culture (5 ml) was 
centrifuged at 4°C for 10 mins at 4000 rpm, and the bacterial pellet was 
resuspended with 250 μl Buffer P1. Cells were lysed by adding 250 μl Buffer P2 
and inverting 6-8 times gently. Then 350 μl Buffer N3 was used to neutralised the 
lysate, and the lysate was centrifuged for 10 mins at 13000 rpm. The supernatant 
was transferred to a miniprep column and spun for 1min at 13000 rpm, then the 
column was washed by adding 750 μl Buffer PE and spun again for 1min at 13000 
rpm. Next, the column was left to dry by centrifuging for 1 min at 13000 rpm, then 
resuspended in 50 μl nuclease-free water, and incubated for 1 min at room 
temperature. Finally, the volume was centrifuged for 1 min at 13000 rpm to elute 
the DNA.   
DNA was extracted from large-scale volumes with PROMEGA® Midi-Prep. 
According to manufacture protocol, 300 μl bacterial culture was mixed with 300μl 
50% glycerol to make a long-term glycerol stock at -20°C. The culture was 
centrifuged at 4°C for 10 mins at 4000 rpm (make sure the balance of each bottle 
pair), and the bacterial pellet was resuspended with 6ml cell resuspension solution. 
Cells were lysed by adding 6 ml cell lysis solution and inverting the tubes 6-8 times 
gently, then incubating at room temperature for 3 mins. Then 8 ml cell neutralisation 
solution was used to neutralised the lysate, and the supernatant was centrifuged 
for 30 mins at 4000 rpm. The columns were assembled on the vacuum manifold, 
and the supernatant was poured into the top of the column and apply vacuum. Then 
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the white filter (DNA binding filter) was washed by adding 5 ml Endotoxin Removal 
Buffer and washed again. The column filter was left to dry for several minutes, then 
600 μl nuclease-free water was overlaid on the column filter, applied the vacuum 
again to elute the DNA. The NanoDrop® Spectrophotometer was used to measure 
the DNA concentration (ng/μl). 
     4.2.3 Restriction digest and gel electrophoresis 
Restriction enzyme digestion was used to identify the correct plasmid DNA. 
Reagents in the reaction mix included 2 μl DNA sample, 2 μl fast digest green buffer 
(10X), 2 μl 10%BSA, 0.2 μl restriction enzyme (the enzymes were used depended 
on the DNA plasmid we choose) to a total volume of 20 μl with ultrapure water 
(pyrogen-free, DNase-free, RNase-free), incubated the mix at 37℃ for 10 min. The 
agarose gel was made by dissolving 1% agarose powder into TAE (1X) buffer using 
a microwave oven, then added 2 μl of SYBR® safe DNA gel stain per 100 ml gel 
after the gel had cooled down. The gel was then poured into a chamber with a comb 
so that wells could be created. 8 μl of 1KB GeneRular ladder (MBI Fermentas®) 
was added into the first well, then the reaction samples were transferred into each 
well of agarose gel in order. The gel was run at an appropriate voltage for 
approximately 45-60 mins to separate DNA fragments by size as well as to visualise 
the DNA isolation and purification. DNA binds were analysed on a short-wave UV 
transilluminator (Bio-Rad® Gel Doc™ 1000). 
 
4.3 CEACAM overexpression and HSV-1 infection assay 
Cells were seeded at 1.5 x 104 cells/well for HeLa cells or 2.0 x 104 cells/well for 
293T cells in 96-well black plate, in a total volume of 100 μl each well. The plate 
was incubated in the 37°C/5% CO2 humidified incubator overnight. The next day, 
pCR3-CEACAM genes were diluted in sterile water to 100 ng/μl. The transfection 
reaction included 1 μl DNA, 18.8 μl OPTIMEM Reduced Serum Medium (Gibco® 
by Life Technologies™) and 0.2 μl Lipofectamine Reagent® 2000 (Invitrogen®) 
was incubated at room temperature for 10-15 min. The media was removed and 
replaced with 80 μl DMEM medium (no pen-strep) each well. 20 μl the reaction mix 
was transferred into each appropriate well. The plate was placed in the 37°C/5% 
CO2 humidified incubator. After 24 hrs, HSV-1 virus stock was thawed rapidly in a 
37℃ water bath and diluted to a multiplicity of infection (MOI) 0.5. The medium was 
removed from plate, and either added 25 μl diluted virus or 25 μl (uninfected control) 
in triplicate and incubated 1 hr at 37°C, then replaced with 100μl phenol red-free 
22 
 
DMEM medium in each well. After 22 hrs of post infection, the viral growth was 
measured every 2 hrs by fluorescence in a plate reader (BMG LABTECH®).   
 
4.4 LUMIER assay 
Luminescence-based mammalian interactome mapping (LUMIER) assays were 
carried out to detect protein-protein interactions. It simplified the protein-protein 
interaction test significantly due to the direction range of luciferase reporter is 
sensitive and highly dynamic (Fig.4).  
 
 
Figure 4: The principle of LUMIER assays. Two proteins are transiently expressed into 
mammalian cells, after lysing cells, the affinity tag is used for affinity purification of protein X 
on IgG-coated magnetic beads, the luciferase tag is used for detection of protein Y (Blasche & 
Koegl, 2013). 
293T cells were seeded at a density of 1.5 x 104 cells/100μl/well in 96-well plate, 
after incubating at 37°C for 24 hrs, the cell confluence was 60-70% approximately. 
Then the transfection complexes were prepared as a total volume of triplicate. For 
one single well of 96-well plate, the mix contained 25 ng pLUM DNA (DNA dilution: 
50 ng/μl), 25 ng pTREX DNA (DNA dilution: 50 ng/μl), 0.2 μl Lipofectamine 
Reagent® 2000 (Invitrogen®) reagent and 18.8 μl OPTIMEM Reduced Serum 
Medium (Gibco® by Life Technologies™). he complexes were incubated for 10-15 
min at room temperature, removed medium from 293T cells plate and added 80 μl 
of no pen-strep growth medium to each well instead, then carefully added 20 μl 
transfection mix to each well and returned the plate to incubator. After 48 hrs, the 
transfected cells were lysed with 10 μl cell lysis buffer (Appendix A) per well which 
contained the washed Dynabeads (M-280 sheep anti-rabbit IgG, Novex® by Life 
Technologies™). Cells were lysed on ice for 30 mins or put in the freezer instead 
until use. The substrate for luciferase measurement was prepared in a 50ml tube 
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(Appendix A) and covered with foil for at least 30 mins at room temperature. Then 
the luciferase activity was measured by separating the lysed cells into two plates. 
Background binding plate (activity plate) contained 90 μl PBS (1X)/well in a black-
white 96-well plate, then added 10 μl of each sample/well, leave 5mins at room 
temperature before measuring. The activity plate gave the background luciferase 
activity in lysed samples. For the specific binding plate, the remaining cell lysate 
was transferred to another black-white 96-well plate, held on magnet for 1 min, and 
carefully remove the supernatant. The plate was washed with PBS (1X)/1mM DTT 
buffer 4-6 times, then replaced with 100 μl PBS(1X) per well (slow and careful wash 
so as not to lose beads). The specific binding plate showed the proteins bound to 
the beads only, but not the background binding of proteins to the beads (see below). 
Finally, luciferase activity was measured with plate reader (BMG LABTECH®) by 
adding 70 μl substrate (Appendix A) per well.  
Furthermore, in our experiment, we measured four values of each sample: 
background binding (input), specific binding (bound), and negative controls for both 
of the ‘’input’’ and ‘’bound’’. Then we calculated the endpoints using the formula: 
log(specific) / log(background) - log(specific negative control) / log(background 
negative control), and normalized z-score by subtracting the mean from each value 
and dividing by the standard deviation. 
 
4.5 Early entry experiments 
CHO cells were seeded at 1.5 x 104/100μl per well as required in 96-well plate and 
incubated overnight at 37°C. The transfection reaction was prepared, each well 
included 60 ng empty pCR3, 60 ng HVEM/Nectin (100 ng/μl), 40 ng ICP4 or ICP27 
promoter (100 ng/μl), 18.75 μl OPTIMEM and 0.25 μl Lipofectamine® 2000 
reagent. Incubated the reaction 15 mins at room temperature, replaced the CHO 
cells plate with 80 μl no antibiotics growth medium per well. Then added 20 μl 
reaction mix to each appropriate well, incubated in the at 37°C/5% CO2 humidified 
incubator. After 24 hours, infected cells with 25 μl of DMEM/F-12 infection medium 
with HSV-1 C12 at MOI 5 dilution, or with 25 μl growth media only as uninfected 
control. For synchronous infection, plate was put on ice for 1 hr, then transferred 
into 37°C/5% CO2 incubator for 1hr. Bound virus was removed by acid wash cells 
with sterile citrate buffer (Appendix A), 50 μl buffer was added per well for 1min 
before washing 3-4 times with 100 μl/well of PBS, and replacing with 100 μl/well 
growth media, then returned to incubator. After 8hrs, the medium was removed and 
cells were lysed by adding 30 μl 1X Passive Lysis Buffer (Appendix A) to each well, 
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covered the plate with an adhesive seal and placed on ice for 30 mins. Cell lysates 
were transferred into a black 96-well plate with inner white well. 30 μl luciferase 
regent (light sensitive) was added to each well before luciferase activity was 
measued. 
 
4.6 Co-Immunoprecipitation assay 
293T cells were seeded at 5 x 106 cells per 10 cm dishes in 10 ml growth medium 
and incubated at 37°C overnight. The next day, the media was removed from the 
dish and vaccinia virus was diluted at an MOI of 10 in DMEM medium (without 
serum or antibiotics), then cells were infected and incubated for 1 hr. Then 
transfection reaction was prepared per dish, including 4 μg of each required DNA 
and 24 μl Polyethylenimine (PEI) and 950 μl OPTIMEM, and mixed in one 1.5 ml 
eppendorf tube, incubated for 30 min at room temperature. All viral inoculum was 
discarded from dish and replaced with the transfection reaction dropwise and 9ml 
no pen-strep/5%FCS media followed by incubating in the 37°C/5% CO2 incubator. 
After 48 hours, cells were detached by pipetting media up and down and transferred 
into a centrifuge tube. The supernatant was discarded after centrifuging, and cells 
were washed in 10 ml PBS and centrifuged again to remove the supernatant. 1.5 
ml NP40 buffer (Appendix A) was added to the cell pallet and lysed cells on ice for 
30 mins or in the freezer. Then the pallet cells were centrifuged and the supernatant 
was transferred to a clean 1.5 ml eppendorf tube. Protein amounts in each sample 
were quantified using the Pierce BCA assay Kit (Thermo®) as per instruction using 
a clear 96-well plate. According to the manufacture protocol, BCA working reagent 
was prepared (A: B=50:1) and added 200 μl/well, then 25 μl of each standard (A to 
I) or 25 μl sample was added to each appropriate well, incubated 30 mins at 37℃. 
Finally, the absorbance (near 562nm) was measured on the plate reader (BMG 
LABTECH®) after the plate was cooled to room temperature.  
The total volume of beads needed for either pre-clearing (25 μl beads per sample) 
or antibody-specific (40 μl beads per sample) binding was calculated as required. 
Beads (Protein G Sepharose™ 4 Fast Flow) were washed 3 times with 1 ml NP40 
buffer (Appendix A) before replaced with the initial volume of NP40 buffer. Then 25 
μl of washed beads were added to the cell supernatant to pre-clear samples. 5 μl 
of anti-Myc antibody (Mouse monoclonal IgG, Santa Cruz Biotechnology™) was 
added to pre-coat beads per sample. Both pre-clearing beads and antibody-coated 
beads were incubated at 4°C for 1 hr in an overhead rotator. Then beads were 
centrifuged and resuspended with antibody-coating beads and an initial volume of 
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NP40 buffer (5 μl per sample). Finally, 40 μl of antibody-coated beads were added 
into each labelled new tubes, the needed volume of pre-clearing sample was 
calculated as 200 ug of each protein, and the accurate volume of supernatant was 
added to each appropriate tube. Then samples were incubated overnight at 4°C in 
an overhead rotator.  
For western blot, the resolving gel (Appendix A) was overlaid at the bottom and the 
stacking gel (Appendix A) on the top of the back plate. The comb was inserted 
quickly without air bubbles around the teeth, left until polymerise. The casting 
apparatus was then moved to the gel running tank which filled with running buffer 
(1X) (Appendix A).  The samples were transferred alongside to each well plus the 
ladder (Spectra™ multicolour broad range ladder) in the first well. Running the gel 
until the last ladder band below the weight of protein was just at the bottom of gel. 
The proteins were transferred from gel to nitrocellulose membrane by semi-dry 
transfer, then rinsed in TBST (1X) (Appendix A). The membrane was blocked with 
5% milk in TBST (Appendix A) overnight. The next day, the membrane was 
incubated with diluted primary antibody (Rat α-HA) (see Appendix B for the 
antibody dilution) for 1hr at room temperature on the shaker after the block milk 
was removed. After 1hr, washed the membrane three times with TBST on the 
shaker for 30 min in total. Then the diluted secondary antibody (α-rat-HRP) (see 
Appendix B for the antibody dilution) was added to incubate the membrane for 
another 1hr on the shaker, repeated washing and rinsed the membrane in PBS 
(1X) (Appendix A) for 5 min. 3 ml Electrochemiluminescence (ECL) developing 
substrate (Pierce™ ECL Western Blotting Substrate, Thermo Scientific™) was 
overlaid on the membrane for 5 min, then put the membrane into development 
cassette after the ECL was removed. Finally, the photo film (Kodak®) was exposed 












5.1 Overexpression of CEACAM proteins increases susceptibility to HSV-1 
infection 
In order to investigate whether CEACAM proteins could increase HSV-1 viral 
replication, we used gain-of-function overexpression experiments. HeLa or 293T 
cells were transiently transfected with either pCR3 vector or CEACAM plasmids 
before infected with HSV-1 virus, the green fluorescence protein (GFP) was 
working as a function of the fluorescence reporter, and the HSV-1 viral replication 
was measured after 22-24 hrs post-infection until 44-46 hrs by detecting the level 
of GFP signal. In comparison to the fluorescence between CEACAM expressing 
cells and control cells (with pCR3 only), then the slop was normalised by analysing 
CEACAMs against pCR3 from replication growth carve. The charts below show the 
summary of several times repeating of this experiment in each cell line without 
outliers (Fig.5). Therefore, we could confirm that CEACAMs overexpression had a 
positive effect on HSV-1 viral replication. Specifically, overexpression of CEACAM7 
and CEACAM8 increased viral replication by approximately twofold.      
A)                                               































































































































































Figure 5: Overexpressed CEACAM proteins increased HSV-1 viral replication 
prominently. A) HeLa cells (seeded at 1.5x104 cells in per 100μl well) were infected with HSV-
1(-GFP) at MOI 0.5 after transfected with either pCR3 or CEACAM proteins, the viral 
replication was measured every two hours after 22hrs post infection until 44hrs. B) 293T cells 
(seeded at 2.0x104 cells in per 100μl well) were infected with HSV-1(-GFP) at MOI 0.5 after 
transfected with either pCR3 or CEACAM proteins, the viral replication was measured every 
two hours after 24hrs post infection until 46hrs. The pCR3 worked as background control, the 
error bars showed the standard deviation based on the triplicates of each CEACAM. 
 
5.2 Confirmation of the interaction between CEACAM proteins and HSV-1 
viral glycoproteins  
As the interaction between HSV-1 viral glycoprotein and CEACAMs had been 
previously identified via Y2H system (see “introduction 2.3.2”), luminescence-
based mammalian interactome mapping (LUMIER) assays were carried out to 
confirm these interactions specifically in mammalian cells. Briefly, CEACAMs and 
glycoproteins were in pLUM and pTREX vectors respectively with both vector 
directions (CEACAM-pLUM/glycopretein-pTREX; CEACAM-pTREX/glycopretein-
pLUM). The charts below show the summary of five times independent repeating. 
The result identified CEACAMs could interact with glycoproteins on both vector 
directions (Fig.6). It can be seen that all the positive bars indicated the interaction 
between CEACAMs and glycoproteins. gB (in LUM) interacted with CEACAM5, 
CEACAM8, CEACAM16 and CEACAM19, gD (in LUM) also interacted with 
CEACAM8, CEACAM16 and CEACAM19. Particularly, the strong interaction 























































Figure 6: The interaction between CEACAMs and glycoproteins was confirmed. Both 
CEACAM and glycoprotein were transiently transfected into each appropriate 293T cell well 
(seeded at 2.0x104 cells in per 100μl well). After 48hrs, cells were lysed with buffer contained 
magnetic beads. Then luciferase activity was measured with lysed samples by the separate 
background binding plate and specific binding plate. A) The interaction between CEACAM (in 
pLUM) and glycoprotein (in pTREX). B) The interaction between CEACAM (in pTREX) and 
glycoprotein (in pLUM). The error bars showed the standard deviation based on the triplicates 
of each CEACAM and glycoprotein interaction pair. Two pairs of proteins (JUN&FOS and 
SPZ1&E7) known to interact were used as positive control, the additional control was each gene 
of interest (CEACAM or glycoprotein) in pLUM was tested against protein A in pTREX in 
order to determine any false-positive interaction (this control pair didn’t show on the figure). 
(C=CEACAM, g=glycoprotein) 
 
5.3 CEACAM7 can bind to glycoprotein H (gH) is proved through Co-
Immunoprecipitation  
In order to further validate the interaction between CEACAM proteins and gH 
(revealed in the previous LUMIER result), we used a second approach to test this 
proteins interaction which was co-immunoprecipitation. The recognised protein 
(antigen) is termed bait, which enable to catch prey protein. CEACAM proteins were 
attached with the bait protein and gH in prey, bait had MYC tag and prey had HA 
tag. Reversely, gH in bait and CEACAMs in prey.  
In this experiment, after the interaction took place, it can be seen that the bind of 




























































































intensity of CEACAM7/gH bind (the red square on left side) was much higher than 
the CEACAM7/empty-bait bind (the red square on right side), which confirmed the 
interaction between CEACAM7 and gH (Fig.7). 
 
Figure 7: CEACAM7 was detected to bind with gH. Both CEACAM7 and gH were 
transiently transfected into each appropriate 293T cells (seeded at 5.0x106 cells in per 10ml dish) 
before infected with vaccinia virus at MOI 10. Cells were lysed after 48hrs and pre-cleared with 
sepharose beads, followed by pulling down with anti-MYC (α-MYC) antibody coated beads. 
Then the antibody coated samples were separated based on the weight of proteins via western 
blot and transferred to the nitrocellulose membrane. The primary antibody (anti-HA or α-HA) 
and secondary antibody (α-rat-HRP) were introduced to stain the membrane after the membrane 
had been blocked. Finally, the membrane was developed and the X-ray film was exposed for a 
appropriate length of time. The film above showed the 10-second exposure. Empty bait group 
with CEACAM7 (in prey) worked as the background (reference value) in comparison to the gH 
(in bait)/CEACAM7 (in prey) pairs. 
 
5.4 CEACAM proteins promote early HSV-1 infection events 
Given the ubiquitous expression of the known HSV entry receptors, it can be 
experimentally challenging to demonstrate a novel protein is acting as a receptor. 
One way can be done is to express potential receptors on viral non-permissive cell 
lines (such as CHO cells). 
We used the luciferase assay to determine whether members of the CEACAM 
protein family act as a receptor for HSV-1 viral early entry infection. As presented 
in the introduction section, the VP16 protein which is in the tegument of the HSV-1 
viral particle is a transcription factor. When the virus enters into CHO cells, VP16 
can bind to the promoter DNA sequence and drive gene transcription, specifically 
the very first stage is the binding with the immediate-early (IE) gene promoter. In 
our lab, we have gene promoter (ICP27) which offers the region for VP16 to bind, 
driving a luciferase reporter. CEACAM proteins have been constitutively 
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overexpressed into CHO cell lines, CHO cells were non-permissive for HSV-1 so 
that the expected increase of infection would validate the role of CEACAM as 
receptors.  
The results indicated the significant increase of all the infected CHO-CEACAMs 
transfected with HVEM, also the infection enhanced for CEACAM3, CEACAM5, 
CEACAM16 and CEACAM19 with Nectin, which demonstrated that CEACAM 
enabled to work as the co-receptor with either HVEM or Nectin (Fig.8). 
 
Figure 8: CEACAM proteins have a positive influence on HSV-1 early entry. CHO cells 
(seeded at 1.5x104 cells in per 100μl well) were infected with HSV-1(-GFP) at an MOI of 5 after 
transiently transfected with ICP27 gene and either pCR3 or HVEM/Nectin, cells were lysed 
after 8hrs post infection and the luciferase activity was measured. For data analysis, non-infected 
CHO-CEACAM cells with pCR3 was the background control (the no virus pCR3 bar didn't 
show on the figure), and calculated the average of each CEACAM triplicates and normalised 
against the average of CEACAM-pCR3 cells (no virus) individually, finally calculated the mean 
and standard deviation of each normalised CHO-CEACAM. The error bars showed the standard 








































6.1 Result analysis   
    6.1.1 HSV-1 viral replication increase prominently with overexpressed 
CEACAMs 
CEACAM proteins were overexpressed based on the gain-of-function 
overexpression experiment, and the obvious increase of HSV-1 viral replication 
were detected after 22-24 hrs post-infection. The two bar charts showed the 
increase level in both HeLa cells and 293T cells. All the CEACAM bars were 
enhanced compared with the pCR3 control, especially CEACAM7, CEACAM8 and 
CEACAM21 increased approximately 60% in HeLa cells, and CEACAM5, 
CEACAM7 also presented the much higher viral replication in 293T cells. The error 
bars from each triplicate group may due to the confluence of cells in each cell well 
or the inequality of virus overlay.  
    6.1.2 Protein-protein interaction through LUMIER and Co-IP 
The interaction between CEACAMs and glycoproteins was confirmed via LUMIER 
assay. It seems that CEACAM7 and CEACAM 8 interacted better with both gB and 
gD than other CEACAM proteins, and also the interaction between 
CEACAM7/CEACAM 8 and gB/gD were much stable than other CEACAM proteins 
from five independent experiments. Whether this phenomenon is based on the 
phenotype or structure of CEACAM proteins is uncertain. For example, CEACAM16 
has special structure which might not contain GPI anchor or TM domain (see 
“Introduction 2.4.1”) to connect with cell membrane, but CEACAM16 enables to 
interact with either gB or gD as well.  
Furthermore, the interaction between CEACAMs and gH was obvious through the 
LUMIER assay. However, this result was completely against the previous studies 
which indicated that the receptor interacted with gH was unidentified (Campadelli-
Fiume et al.,2012).  
Co-IP experiment was carried out in order to further prove that CEACAMs enable 
to interact with gH. As the result, the expected bind of CEACAM7 was shown with 
the molecular weight of 30kDa, and the bind intensity was much higher in 
CEACAM7 with gH than in CEACAM7 with empty bait, which convinced the 
possibility of the interaction between CEACAM7 and gH.  
There were some limitations on both LUMIER assay and Co-IP. From the LUMIER 
side, the Dynabeads were inevitably lost by repeat washing 3-4 times even though 
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beads were sucked down to the magic. From the Co-IP side, the concentration of 
lysed samples influences the volume of needed supernatant for quantifying the 
proteins and coating the antibody. Meanwhile, other factors such as the cell 
confluence, the efficiency of transfection, infection rate may also affect the results. 
In order to minimise the errors, each experiment was repeated 3-5 times 
independently and each protein-protein pair was in triplicates. 
 
6.2 Interaction between CEACAM proteins and gB, gD, gH, gL 
The first stage of HSV-1 entry process is the fusion between the virion envelope 
and a cellular membrane. The entry fusion machinery is influenced by a number of 
determinant factors. In terms of the virus, the major glycoproteins (gB, gD, gH, gL) 
have their specific roles which contribute to the virus-cell fusion. From the cell side 
of view, a plethora of cellular receptors and the routing factors play the key role on 
entry pathway.  
With respect to the function of viral glycoproteins, the fusion activation begins with 
one glycoprotein and transmits to another, all the glycoproteins have mutual 
influence. Initially, gD interacts with one cellular receptor, the binding forms a 
complex of gD and receptor and also results in a conformational change of gD. This 
assembly enables the signal transmit to gH/gL as well as contributing to the 
activation of gB (Fig.9) (Cooper & Heldwein, 2015). 
Figure 9: The function of gB/gD/gH/gL in fusion process. The initial interaction happens 
between cellular receptor and gD on the cell membrane, which triggering a conformational 
change of gD. gH/gL are activated followed by gD structural change and in turn regulates 
activation of gB for its prefusion. (Taken from http://www.mdpi.com) 
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In recent years of studies, several receptors for glycoproteins have been identified. 
As some researches indicated, there are three main cellular receptors for gD, which 
are HVEM, Nectin1/2 and 3-OS HS (see “Introduction 2.2.2.2”). The current known 
receptor for gB is called paired immunoglobulin-like type 2 receptor-a (PILRα) with 
activating function (Satoh et al., 2008). Another receptor for gB is Myelin-associated 
glycoprotein (MAG) which has approximately 5%-12% homology with PILRα 
(Karasneh et al., 2011). Currently, the only confirmed routing factor of HSV-1 entry 
for gH is αVβ-intergrin, but whether there is an interaction between the αVβ-
intergrin and the component of virion particles is unknown (Campadelli-Fiume et 
al., 2012; Gianni et al., 2010a; Gianni et al., 2010b).  
The previous work in Prof. Juergen’s group has shown that some CEACAM 
members were capable of inhibiting the HSV-1 replication via siRNA knockdown 
screen, and working on yeast two-hybrid (Y2H) detected the interaction between 
gH∆sp, gD baits and several CEACAMs preys. Specifically, CEACAM8 (in prey) 
interacted with gH∆sp (in bait) was confirmed. Furthermore, our recent result also 
indicated that several CEACAMs potentially enable to interact with either gB or gD 
(see “Result 5.2” and “Discussion 6.1.2”), which were the further evidences shown 
that CEACAM may serve as the cellular receptor for HSV-1 viral glycoproteins 
(gB/gD).  
Interestingly, previous studies suggested that gH/gL act as the intermediate 
regulators between gB and gD to promote the fusion and as the carrier to load 
binding sites to the cellular receptors. Meanwhile, whether gH/gL could interact with 
a cellular receptor has not yet been identified (Campadelli-Fiume et al., 2012). 
However, our LUMIER data revealed the positive interaction between CEACAM 
proteins and gH (see “Result 5.2”) which fight against the preceding statement of a 
yet unidentified HSV-1 gH receptor. According to our LUMIER result, the g 
interaction between CEACAMs (CEACAM7, CEACAM8, CEACAM16, 
CEACAM19, CEACAM21) and gH can be seen obviously via the strong positive 
bars (see “Result 5.2”), this outstanding data demonstrated that CEACAM is likely 
to be the new receptor for gH, apart from the only known αVβ-intergrin routing 
factor. 
Importantly, the cell species and the receptor classes may also influence the viral 
entry pathway. On the cell side, HSV-1 entry pathway differs in cell types, the direct 
endocytosis into the neutral endosome and virion-cell fusion at the plasma 
membrane are the common routes for the majority of cell species, whilst HSV-1 
may also enter into some special cells via macropinocytosis (Clement et al.,2006). 
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On the receptor side, some routing factors such as αVβ-intergrin do not require 
receptor when shifting to the subdomain of the membrane. The endothelial strain 
of cytomegalovirus needs the special determinants of gH/gL for fusion (Ryckman 
et al.,2008).  
 
6.3 The linkage between HSV-1 and Alzheimer’s disease  
Alzheimer’s disease (AD) is a chronic and devastated neurodegenerative disease 
which the causes are poorly understood and the knowledge of cases are limited 
(Miller & Federoff, 2008). Studies showed that one factor of Alzheimer’s disease is 
age, elder population over 65 years old are likely to be afflicted by AD, especially 
for the people over the age of 85 (Piacentini,et a., 2014). One recent clinical report 
indicated that nearly 35 million people worldwide were attacked by AD in 2010, and 
the number of population was dramatically increasing to approximately 60 million 
by the end of 2015, it is estimated that the peak will reach to 115-120 million by 
2050 (Taken from World Alzheimer’s Report 2015). The main symptom of 
Alzheimer’s disease is dementia, the cognitive function of patients is reducing 
progressively, which leads to short-term memory loss. As time goes on, some more 
clinical manifestations come out followed by the disease advances, including 
motivation loss, lack of self-care ability, disorientation and language barrier (Itzhaki 
et al., 1997; Piacentini,et al., 2014). According to the previous studies, this disease 
process is mainly based on the cerebellar atrophy along with the decrement of 
cerebral function (Porcellini, et al., 2010). 
Apart from the aging, there are several other risk factors for developing the 
alzheimer’s disease, such as hypertension, lifestyle, emotional stimulation 
(depression) as well as genetic risk (Imtiaz et al., 2014). From the genetic point of 
view, the best known risk factor is the carriage of the ε4 allele of the apolipoprotein 
E (ApoE-ε4) which is capable of affecting neurodegeneration diseases (Mahley et 
al., 2000). The unique ApoE-ε4 plays a major role in AD pathogenesis. Meanwhile, 
ApoE-ε4 enables to increase the production of amyloid-beta (Aβ) peptide (the key 
component of senile plaques), and to stimulate the amyloid precursor protein (APP) 
(the cellular transmembrane glycoprotein and receptor), it also effects on the 
formation of the transgenic plaques (Itzhaki et al., 1998; Holtzman et al., 2012; 
Verghese et al., 2013).  
Herpes simplex virus type 1 (HSV-1) DNA is a neurotropic virus which infects 
epithelial cells. As presented in the introduction chapter, primary HSV-1 infection 
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causes the ulcerative lesions such as cold sores. The acute infection undergoes 
the lytic replication, which the newly produced viral particles may migrate back to 
the original binding site via the sensory neurons, causing the recurrence. After the 
acute infection, some HSV-1 particles may conceal in sensory nerve for lifelong, 
which process is called the latent infection. The latent viruses typically persist in the 
trigeminal ganglia located in the brainstem, and these reactivated viral particles 
come from the repeated HSV-1 replication cycle may finally reach the central 
nervous system through blood stream and cause neurological disorders (Burgos et 
al., 2005).  
One molecular study believed that the HSV-1 infected neuronal cells led to an 
intracellular enhancement of Aβ, and a decline of some APP fragments. This event 
showed the similar cellular results in relation to the AD development (Wozniak et 
al., 2007; Chiara et al., 2010). In addition, the dynamic interaction between HSV-1 
capsid and APP facilitates the HSV-1 viral transport inside the infected cells 
(Agostini et al., 2014). Furthermore, ApoE-ε4 carrier has been confirmed to 
influence the establishment of latent infection and the expression of HSV-1 
immediate-early genes using a HSV1-infected AopE-transgenic mice model (Miller 
& Federoff, 2006).  
Genome wide association (GWA) study with several thousands of AD European 
patients demonstrated that few genes (such as Nectin2, CEACAM16, CEACAM17) 
and other host factors (HF) affecting HSV-1 infection were encoded close to the 
AopE region susceptibility locus on chromosome 19 were associated with late-
onset Alzheimer’s disease, and the single nucleotide polymorphisms (SNPs) in this 
region were linked to AD-associated SNPs (Porcellini et al., 2010).  
According to several convincing studies, the hypothesis of the relationship between 
HSV-1 and Alzheimer’s disease is potentially established, but further investigations 
are necessary in order to validate this standpoint. 
 
6.4 Further work 
The interaction between CEACAM proteins and viral glycoproteins has been 
detected via several independent repeating of LUMIER assay, but the positive 
control pair (either JUN/FOS or SPZ1/E7) was unstable based on the previous 
results, so choose a more efficient control pair will be much convincing. 
Alternatively, we could use HVEM receptor to interact with gD through LUMIER 
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simultaneously which the interaction has been confirmed, so that we could better 
confirm the interaction result.  
Due to the result that CEACAM7 enabled to interact with gH, the further work in the 
laboratory will need to test whether other CEACAM proteins (such as CEACAM8, 
CEACAM16) could interact with gH by both immunoprecipitation and co-
Immunoprecipitation assays. Meanwhile, we could test the downregulation of 
CEACAMs with overexpressed gH in mammalian cells through 
immunofluorescence (IF), which is a general biochemical application using confocal 
microscopy. Antibody plays an important role as probe, which aims to label the 
specific antigen with the staining marker fluorescein isothiocyanate (FITC) or DAPI 
(which can pass through the cell membrane) to target the molecule. The 
conjugation between the antibody and fluorophores makes the target protein visible 
under the microscope so that the distribution of proteins is obvious (Bacallao et al., 
2006; Robinson et al., 2009).  
Because of the results for the HSV-1 early entry event with CHO cells are variable, 
we could test other non-permissive cell lines such as Zebrafish, Drosophila which 
are suitable for infection. Also, we could test the CEACAM expression in CHO cells, 
HeLa cells or SK-N-SH cells by quantitative polymerase chain reaction (qPCR). 
Similarly, this technique, which aims to monitor an exponential amplification of 
targeted DNA, also rely on the fluorophore reporter. The accumulating DNA binds 
to the fluorescent dye and the value of fluorescence signal is recorded and the 
number of specific DNA section is doubled during each PCR process cycle, which 
depends on the change of temperature and the thermostability of DNA polymerase 
(Higuchi et al., 1993; Lehmann & Kreipe, 2009).  
In addition, cell fusion assay is another approach to investigate whether CEACAM 
is a new cellular receptor, this technique has been applied to the research of other 
receptors, for example, 3-O HS is the receptor for gD and PILRα is the receptor for 
gB (see “Discussion 6.2”). 
 
6.5 Conclusion 
In this project, we found the significant increase of HSV-1 viral replication by 
overexpressing CEACAM proteins, and the interaction between several CEACAMs 
(such as CEACAM7, CEACAM8, CEACAM16, CEACAM19) and viral glycoproteins 
(gB, gD) was confirmed by LUMIER assay. Specifically, we also identified that 
CEACAM7 was able to interact with gH via Co-IP which fights against the previous 
37 
 
study said that the receptor for gH is unknow. The luciferase assay for HSV-1 early 
entry using viral non-permissive cell (CHO cells) indicated that CEACAM may work 
as the co-receptor with HVEM or Nectin, because CEACAM proteins obviously 
increased the susceptibility of HSV-1 infection and viral replication. Therefore, all 
the convincing results throw light on our hypothesis, which makes us more 





























   Appendix A: 
    Table 1: Materials of making medium and solution 
  Meidum / Solution Materials 
Pen-Strep 100units/ml Penicillin; 100μl/ml Streptomycin. 
5% FCS+1% 
Pen-Strep 
25ml FCS and 5ml P/S dissolved in 500ml DMEM 
PBS (5X) 8.0g/L NaCl, 0.2g/L KCl, 1.42g/L Na2HPO4, 0.24g/L KH2PO4, 
PH=7.4 
Trypsin 0.025% trypsin and 0.01% EDTA in PBS with phenol red 
LB agar 1% (w/v) bacto-tryptone (Difco®), 1% (w/v) sodium chloride 
(Sigma-Aldrich®), 0.5% (w/v) yeast extract (Difco®), 1.5% (w/v) 
agar (Fluka®) 
LB medium 1% (w/v) bacto-tryptone (Difco®), 1% (w/v) sodium chloride 
(NaCl; Sigma-Aldrich®), 0.5% (w/v) yeast extract (Difco®) 
TAE buffer (1X) 0.04 M Tris, 0.001 M EDTA, 0.002 M glacial acetic acid 
Lysis Part1 buffer 22mM Tris PH7.5, 1% TritionX100, 275mM NaCl, 11mM EDTA 
1M DTT 1.5 g of DTT (DL-dithiothreitol) in 8 ml of deionized or distilled 
water, make up to 10 ml 
1mM DTT 0.1M concentration of 1M DTT 
Cell lyse buffer 
(LUMIER) 
Lysis Part1 buffer 900μl, 
Phosphatase inhibitor cocktail (Roche® 04 906 837) 100μl, 
Protease inhibitor cocltail (Roche® 1 836 170) 40μl, 
1M DTT 10μl, 
Benzonase (Novagen® 70746, puritiy>90%, 25 units/μl) 0.5μl 




20ml of 1X PBS, 5M NaCl, 40μl aliquot of Coelenterazine 
Citrate buffer 40mM Citric Acid, 135mM NaCl, 10mM KCl, PH=3.0 
Passive Lysis 
Buffer (1X) 
Dilute Passive Lysis Buffer 5X (Promega®) with water 





7.7ml ddH2O, 4ml 40% Acrylamide, 4ml 1.5M Tris PH8.8, 160μl 
10% SDS, 160μl 10% APS, 16μl TEMED 
6% Stacking gel 7.05ml ddH2O, 1.5ml 40% Acrylamide, 1.25ml 1.5M Tris PH6.8, 
100μl 10% SDS, 100μl 10% APS, 10μl TEMED 
Gel running buffer 
(10X) 




Glycine 29.3g, Tris Base 58.2g, SDS 3.7g, make up to 1 litre 
with water 
TBS (1X) 6.05 g Tris and 8.76 g NaCl in 800 mL of H2O. Adjust pH to 7.5 
with 1 M HCl, make up to 1 litre with water 
TBST (1X) 10% Tween 20 Solution in 1X TBS 
5% milk of TBST  
(5% milk/TBST) 




    Appendix B: 
    Table 2: GATEWAY plasmids  
    Plasmid Alias Antibiotic    Enzymes for restriction digest 
pcDNA-RL-GW pLUM Ampicillin Xhol/Xbal 
pTREX-dest30-
PrA 
pTREX Ampicillin Xhol/Nhel 
pGBKT7 Bait Kanamycin EcoRI/BamHI 
pGADT7-AD Prey Ampicillin EcoRI/BamHI 
 
 
    Table 3: DNA plasmids in stock 
Vector  Gene which has been transformed into the plasmids 
pLUM CEACAM1, CEACAM3, CEACAM5, CEACAM7, CEACAM8, CEACAM16, 
CEACAM19, CEACAM21; 
c-JUN 





Bait CEACAM1, CEACAM3, CEACAM5, CEACAM7, CEACAM8, CEACAM16, 
CEACAM19, CEACAM21; 
c-MYC 
Prey CEACAM1, CEACAM3, CEACAM5, CEACAM7, CEACAM8, CEACAM16, 
CEACAM19, CEACAM21; 
MAX  
pCR3 CEACAM1, CEACAM3, CEACAM5, CEACAM7, CEACAM8, CEACAM16, 






    Table 4: Dilution of antibody in 5% milk/TBST (antibody:milk) 
   IP CO-IP 
Primary antibody Mouse α-MYC (1:2500) Rat α-HA (1:2500) 
Secondary antibody α-mouse-HRP (1:5000) α-rat-HRP (1:5000) 
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